Lipid-lowering agent: Difference between revisions
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
<languages /> | |||
<translate> | |||
<!--T:1--> | |||
{{Drug List/ja}} | |||
{{PathNav|Medication|frame=1}} | |||
{| class="wikitable sortable" style="width:100%" | {| class="wikitable sortable" style="width:100%" | ||
|+脂質降下薬（その他） | |+脂質降下薬（その他） | ||
| Line 12: | Line 17: | ||
|販売 | |販売 | ||
|[[Takeda Pharmaceutical Company]] | |[[Takeda Pharmaceutical Company]] | ||
| | |||
|- | |||
|[[Ethyl eicosapentaenoic acid/ja]] | |||
|[https://med.mochida.co.jp/medicaldomain/circulatory/epadel/index.html エパデール](持田製薬) ([https://med.mochida.co.jp/txt/pdf/epa-s_n22.pdf PI]) ([https://med.mochida.co.jp/interview/epas_n22.pdf IF]) | |||
|販売 | |||
|[[Mochida Pharmaceutical]] | |||
| | | | ||
|- | |- | ||
|} | |} | ||
'''Lipid-lowering agents''', also sometimes referred to as '''hypolipidemic agents''', '''cholesterol-lowering drugs''', or '''antihyperlipidemic agents''' are a diverse group of [[pharmacology|pharmaceuticals]] that are used to lower the level of lipids and lipoproteins such as cholesterol, in the blood ([[hyperlipidemia]]). The American Heart Association recommends the descriptor 'lipid lowering agent' be used for this class of drugs rather than the term 'hypolipidemic'. | '''Lipid-lowering agents''', also sometimes referred to as '''hypolipidemic agents''', '''cholesterol-lowering drugs''', or '''antihyperlipidemic agents''' are a diverse group of [[pharmacology|pharmaceuticals]] that are used to lower the level of lipids and lipoproteins such as cholesterol, in the blood ([[hyperlipidemia]]). The American Heart Association recommends the descriptor 'lipid lowering agent' be used for this class of drugs rather than the term 'hypolipidemic'. | ||